# A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers

> **NCT01371175** · PHASE2 · COMPLETED · sponsor: **International AIDS Vaccine Initiative** · enrollment: 115 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** DNA.HIVA
- **BIOLOGICAL:** MVA.HIVA
- **BIOLOGICAL:** MVA.HIVA
- **BIOLOGICAL:** MVA.HIVA

## Key facts

- **NCT ID:** NCT01371175
- **Lead sponsor:** International AIDS Vaccine Initiative
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-05
- **Final completion:** —
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2011-06-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371175, "A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01371175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*